| 0 (0%) | 09-27 09:27 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.4 |
1-year : | 3.02 |
| Resists | First : | 2.06 |
Second : | 2.58 |
| Pivot price | 1.92 |
|||
| Supports | First : | 1.21 |
Second : | 1 |
| MAs | MA(5) : | 1.51 |
MA(20) : | 2.01 |
| MA(100) : | 1.76 |
MA(250) : | 2.73 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 4.6  |
D(3) : | 3.3 |
| RSI | RSI(14): 26.2 |
|||
| 52-week | High : | 7.5 | Low : | 1.09 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CASI ] has closed above bottom band by 6.0%. Bollinger Bands are 138.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.54 - 1.55 | 1.55 - 1.56 |
| Low: | 1.19 - 1.2 | 1.2 - 1.21 |
| Close: | 1.29 - 1.31 | 1.31 - 1.32 |
Fri, 26 Sep 2025
CASI Pharmaceuticals Strengthens Board with Industry Veteran James Huang - TipRanks
Fri, 26 Sep 2025
James Huang to join CASI Pharmaceuticals board as independent director - Investing.com
Fri, 26 Sep 2025
CASI Pharmaceuticals Appoints James Huang to Board of Directors - ACCESS Newswire
Fri, 26 Sep 2025
35-Year Biotech Veteran James Huang Joins CASI Pharma Board as Company Advances CID-103 Program - Stock Titan
Fri, 26 Sep 2025
Casi Cielo Coffee in Keller extends operating days - Community Impact
Wed, 24 Sep 2025
El monólogo de regreso de Jimmy Kimmel fue visto por casi 6,3 millones en TV, pese a negativa en varias ciudades - Chron
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 15 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 48.3 (%) |
| Held by Institutions | 20.4 (%) |
| Shares Short | 342 (K) |
| Shares Short P.Month | 29 (K) |
| EPS | -2.9 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.31 |
| Profit Margin | -148.6 % |
| Operating Margin | -256.6 % |
| Return on Assets (ttm) | -62.8 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 4.9 % |
| Gross Profit (p.s.) | 0.83 |
| Sales Per Share | 2.03 |
| EBITDA (p.s.) | -2.57 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.46 |
| PEG Ratio | 0 |
| Price to Book value | -1 |
| Price to Sales | 0.64 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|